A phase 2, open-label study of niraparib in women with advanced, relapsed, high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer after ≥3 previous chemotherapy regimens.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS5609-TPS5609 ◽  
Author(s):  
Kathleen N. Moore ◽  
Bj Rimel ◽  
Shefali Agarwal ◽  
John Balser ◽  
Robert E. Martell ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
High Grade ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer

scholarly journals IMCT-04TOCA 5: PHASE 2/3 RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 WITH TOCA FC VERSUS STANDARD OF CARE IN PATIENTS UNDERGOING PLANNED RESECTION FOR RECURRENT HIGH GRADE GLIOMA (NCT02414165)

2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v107.4-v108
Author(s):  
Gelareh Zadeh ◽  
Michael A. Vogelbaum ◽  
Derek Ostertag ◽  
Trinh Le ◽  
Alice Chu ◽  
...  
Keyword(s):  
Standard Of Care ◽  
High Grade Glioma ◽  
High Grade ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Abstract OT-32-01: A phase 2, open-label study of bintrafusp alfa monotherapy in patients withHMGA2-expressing triple-negative breast cancer

2021 ◽  
Author(s):  
Leisha A Emens ◽  
Margaret E. Gatti-Mays ◽  
Joyce O’Shaughnessy ◽  
Luc Dirix ◽  
Giovanni Faggioni ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals 1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study

2018 ◽  
Vol 5 (suppl_1) ◽  
pp. S562-S563
Author(s):  
Sarah Mische ◽  
Robert Orenstein ◽  
Erik R Dubberke ◽  
Sahil Khanna ◽  
Gail Hecht ◽  
...  
Keyword(s):  
Clostridium Difficile ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document